Chemed Corp. buy Royal Bank of Canada
Start price
28.04.25
/
50%
€492.00
Target price
28.04.26
€593.59
Performance (%)
-21.14%
Price
29.08.25
€382.00
Summary
This prediction is currently active. The prediction for Chemed Corp. disappoints with a performance of -21.14%. This prediction currently runs until 28.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Chemed Corp. | -1.546% | -1.546% |
| iShares Core DAX® | -1.740% | -1.152% |
| iShares Nasdaq 100 | -0.157% | -0.813% |
| iShares Nikkei 225® | -1.705% | 3.309% |
| iShares S&P 500 | 0.148% | 0.240% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Chemed Corp. diskutieren
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $667.00 to $674.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat